PRESS RELEASE published on 05/05/2026 at 22:07, 5 months 6 days ago Informations privilégiées / Autres communiqués Advicenne annonce l'ouverture d'une procédure de sauvegarde pour restructurer son passif financier et finalise l'extension de son horizon de trésorerie. La société pharmaceutique spécialisée en maladies rénales rares vise à poursuivre ses activités sous protection juridique Trésorerie Restructuration Procédure De Sauvegarde Endettement Advicenne
BRIEF published on 03/26/2026 at 20:14, 6 months 16 days ago Aperçu financier d'Advicenne pour 2025 : Résultats mitigés et perspectives d'avenir Croissance Des Revenus Approbation De La FDA Advicenne Résultats Financiers 2025 Sibnayal®
BRIEF published on 03/26/2026 at 20:14, 6 months 16 days ago Advicenne presents its 2025 annual financial results Financial Results Treasury Sales Growth Clinical Development Sibnayal®
BRIEF published on 03/26/2026 at 20:14, 6 months 16 days ago Advicenne's 2025 Financial Overview: Mixed Results and Future Prospects Revenue Growth FDA Approval Advicenne Financial Results 2025 Sibnayal®
BRIEF published on 03/26/2026 at 20:14, 6 months 16 days ago Advicenne présente ses résultats financiers annuels 2025 Résultats Financiers Croissance Des Ventes Trésorerie Développement Clinique Sibnayal®
PRESS RELEASE published on 03/26/2026 at 20:09, 6 months 16 days ago Inside Information / News release on accounts, results Advicenne reports its 2025 annual financial results, including a 18.7% increase in product sales, Sibnayal®'s growth in Europe, and the expected US Marketing Authorization. The company aims to extend its cash runway and restructure its balance sheet Financial Results Advicenne Marketing Authorization Cash Runway Sibnayal
PRESS RELEASE published on 03/26/2026 at 20:09, 6 months 16 days ago Informations privilégiées / Communiqué sur comptes, résultats Advicenne annonce ses résultats financiers 2025: chiffre d'affaires en hausse, ventes européennes de Sibnayal® en progression, doublement des royalties et horizon de financement à mi T2 2026. Approbation des comptes par le Conseil d'administration Chiffre D'affaires Résultats Financiers Advicenne Sibnayal® Horizon De Financement
BRIEF published on 01/19/2026 at 07:35, 8 months 23 days ago La FDA examine le Sibnayal® d'Advicenne en vue de son approbation aux États-Unis. FDA Advicenne Sibnayal® DRTA Date PDUFA
BRIEF published on 01/19/2026 at 07:35, 8 months 23 days ago FDA Reviews Advicenne's Sibnayal® for U.S. Approval FDA Advicenne Sibnayal® DRTA PDUFA Date
BRIEF published on 01/19/2026 at 07:35, 8 months 23 days ago Advicenne: FDA-approved marketing application for Sibnayal® FDA ATRd Advicenna Sibnayal® PDUFA
Published on 10/10/2026 at 04:45, 1 day 17 hours ago Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 1 day 20 hours ago BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/10/2026 at 02:00, 1 day 20 hours ago Battery X Metals Reports Estimated Driving Range Increase of Approximately 101 Kilometers Following a Single-Electric-Vehicle Performance Evaluation of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Technology
Published on 10/09/2026 at 23:00, 1 day 23 hours ago Trans Canada Gold Closes First Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,144,720
Published on 10/09/2026 at 22:15, 2 days ago Loop Industries to Host Second Quarter Fiscal 2027 Earnings Conference Call
Published on 10/10/2026 at 16:35, 1 day 5 hours ago New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026
Published on 10/10/2026 at 16:30, 1 day 5 hours ago ZPMC-Built Infrastructure Supports China's First Offshore Wind Project to Deploy 18 MW Turbines at Scale
Published on 10/10/2026 at 10:05, 1 day 12 hours ago ONLYOFFICE 10.0 brings AI tools, modular apps, and stronger security to its open-source office suite
Published on 10/09/2026 at 21:24, 2 days ago Branicks Group AG: Extraordinary General Meeting does not approve all items on the agenda
Published on 10/09/2026 at 21:17, 2 days 1 hour ago EQS-Adhoc: Branicks Group AG: Agenda topic four at extraordinary general meeting rejected
Published on 10/09/2026 at 19:27, 2 days 2 hours ago Disclosure of transactions in own shares from October 1 to October 9, 2026
Published on 10/09/2026 at 19:27, 2 days 2 hours ago Déclaration hebdomadaire d'opérations effectuées du 1er au 9 octobre 2026
Published on 10/09/2026 at 17:45, 2 days 4 hours ago Déclaration des droits de vote à fin septembre 2026